492 Million Products Recalled Across Food, Pharma, and Autos in Early 2026

Consumer goods were the only sector to record an increase in recall events, rising from 124 to 142 recall events during the quarter.

Kelly McBride Ni

Published: 5/19/2026, 5:24:17 PM EDT

492 Million Products Recalled Across Food, Pharma, and Autos in Early 2026 — The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. (Madalina Vasiliu/The Epoch Times)

The United States experienced a historic surge in product recalls during the first quarter of 2026, with nearly 492 million items—including food, medications, vehicles, children’s products, medical devices, and household goods—removed from shelves nationwide due to safety concerns, according to a new report tracking U.S. recall data.

Sedgwick’s latest U.S. Product Safety and Recall Index found that recalled products jumped 27 percent from the previous quarter, rising from 387.7 million to 492.3 million products.

However, the report found that 785 recalls were issued during the quarter, down from 877 in the prior quarter. This means that 92 more recalls occurred last quarter, but more products were recalled this quarter. Consumer products were the only major category to post an increase in recall events.

The findings point to growing pressure across supply chains and manufacturing systems as regulators increase scrutiny over contamination risks, labeling failures, product defects, and sourcing practices. The report says companies are now facing higher risks of regulatory action and reputational damage due to the sheer scale of recent recalls.

"The ongoing economic uncertainty should urge companies to control what they can do, including assessing their compliance risk and evaluating their recall plans against a dynamic regulatory environment," said Senior Vice President Chris Harvey at Sedgwick.

"The current administration is emphasizing transparency with a focus on product origin information and food ingredients,” he said, adding that “Clear communication is another priority with consumers, suppliers, and regulators. Businesses should ensure that they have effective communication channels in place and can support any statements they make."

Pharmaceutical Recalls Hit 12-Year High

The pharmaceutical sector recorded the most dramatic increase, with recalled drug products surging to 218.8 million units, or individual products, the highest quarterly total in 12 years.

This spike was largely driven by a single recall of antiseptic towelettes, hand sanitizers, and related products containing benzalkonium chloride, which accounted for more than 212 million recalled units.

Sedgwick said the increased pharmaceutical recalls were largely tied to manufacturing problems, contamination concerns, failed quality specifications, and labeling issues that can pose patient safety risks.

The leading cause of pharmaceutical recalls was failed specifications, followed by foreign materials, then sterility.

“Sterility was second by volume, affecting approximately 3.87 million units, driven largely by a recall of 3.11 million eye drops,” states the report. Meanwhile, foreign materials affected 1.11 million pharmaceutical products.

Food Recalls Remain Elevated

According to the report, FDA-regulated food recalls nearly doubled, reaching 57.4 million products. Food recalls were driven by contamination, undeclared allergens, and foreign materials, prompting large-scale safety actions.

Undeclared allergens were the leading cause of recalls, with milk and soy among the most common ingredients involved.

Foreign materials, including glass contamination, accounted for the largest number of recalled food products by volume.

The U.S. Department of Agriculture reported 37.1 million pounds of recalled food during the quarter, one of the highest totals in more than 20 years, according to the report.

Consumer Product Recalls Climb Sharply

Consumer goods were the only sector to record an increase in recall events, rising from 124 to 142 recall events during the quarter.

“From product safety enforcement to forced‑labor investigations, brands are being held accountable for compliance failures across the entire supply chain,” states the report.

Products intended for children and infants drew heightened scrutiny. Recalls for toys and children’s products reached their highest levels in more than a decade and doubled from the previous year.

The report cited risks including choking hazards, electrical failures, battery malfunctions, and toxic substance exposure.

Federal regulators have also expanded oversight to investigate forced labor in global supply chains and false “Made in USA” claims.

In March, the Office of the United States Trade Representative launched investigations involving 60 trading partners over the enforcement of bans on imported goods produced with forced labor.

The Consumer Product Safety Commission also announced an $11.5 million civil penalty against a bicycle parts manufacturer accused of failing to quickly report defective cranksets that posed serious injury risks.

Auto Recalls Remain Historically High

The automotive sector recorded more than 12 million recalled vehicles during the quarter, one of the highest quarterly totals in recent years.

Electrical system failures accounted for the largest share, followed by visibility problems, braking defects, and back-over prevention system issues.

Safety oversight is led by the National Highway Traffic Safety Administration, which is also monitoring the increasing complexity in vehicle electronics, software, and advertising practices.

In March, the Federal Trade Commission sent warning letters to 97 dealerships nationwide for illegal vehicle pricing and advertising.

Medical Devices

Sterility issues were the leading cause of medical device recalls by volume in the first quarter of 2026, affecting 86.35 million units, according to the report.

The vast majority of these units—86.07 million—were linked to a single large-scale recall of convenience kits containing prepacked medical devices.

Mislabeling was the second most common reason, with 19.60 million units recalled, driven largely by a recall involving 18.15 million user manuals for blood glucose measurement devices. Leakage ranked third, with 16.47 million units impacted, including a major recall of 14.68 million hemodialysis connectors.